BGMS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BGMS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Bio Green Med Solution Inc BGMS
Bio Green Med Solution BGMS -5.36% 47 Tariff Resilience Score is 6 as of Jul. 03, 2026. GuruFocus rates BGMS with a GF Score™ of 47/100 and a GF Value™ of $2.56 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 1,374 Biotechnology companies, Bio Green Med Solution ranks better than 75.98% on this metric.
Bio Green Med Solution has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.
Bio Green Med Solution has Cyclacel Pharmaceuticals Inc faces moderate tariff risks due to its reliance on international supply chains for drug development. The company can mitigate these risks through strategic partnerships and alternative sourcing.
Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.
The company's exposure to international trade tariffs based on these criteria:
1. Global supply chain dependenciesBased on the research, GuruFocus believes Bio Green Med Solution might have Average Resilient.
Bio Green Med Solution (NAS:BGMS) Tariff Resilience Score Explanation
The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:
| Tariff Resilience Score | Resilience Level |
| 7 - 10 | Highly Resilient |
| 4 - 6 | Average Resilient |
| 0 - 3 | Highly Vulnerable |
For the Biotechnology subindustry, Bio Green Med Solution's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Bio Green Med Solution's Tariff Resilience Score distribution charts can be found below:
* The bar in red indicates where Bio Green Med Solution's Tariff Resilience Score falls into.
Based on GuruFocus' analysis, Bio Green Med Solution stock appears to be undervalued. The current stock price of $1.06 is trading 58.6% below its estimated GF Value™ of $2.56. GuruFocus considers Bio Green Med Solution to be Possible Value Trap.
Key valuation signals for BGMS:
No single metric tells the full story. See the BGMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.